+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Heart Attack Diagnostics Market by Product Type, Technology, End User, Application - Global Forecast to 2030- Product Image
Heart Attack Diagnostics Market by Product Type, Technology, End User, Application - Global Forecast to 2030- Product Image
Sale

Heart Attack Diagnostics Market by Product Type, Technology, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674421
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The heart attack diagnostics market is entering a transformative period defined by advanced technologies, new clinical workflows, and shifting regulatory landscapes. This executive overview delivers sector insights tailored for senior healthcare and diagnostics executives seeking actionable intelligence.

Market Snapshot: Heart Attack Diagnostics Market

The Heart Attack Diagnostics Market grew from USD 14.96 billion in 2024 to USD 16.16 billion in 2025. With a projected CAGR of 7.80%, it is forecast to reach USD 23.49 billion by 2030. Despite regulatory pressures and cost containment initiatives, adoption of high-sensitivity biomarker tests and digital point-of-care solutions continues to expand, supported by investments in imaging and remote monitoring. Market expansion is bolstered by increased healthcare modernization in emerging economies and the integration of digital health tools into established care models.

Scope & Segmentation

This research report analyzes the heart attack diagnostics segment across multiple dimensions to enable targeted decision-making and opportunity identification:

  • Product Types: Biomarker testing (CK-MB, Troponin I, Troponin T), electrocardiography (resting and stress ECG), and imaging (computed tomography, magnetic resonance imaging).
  • Technologies: Laboratory-based platforms (including high-sensitivity troponin assay, immunoassay) and point-of-care (handheld and portable devices).
  • End Users: Ambulatory care centers, diagnostic centers, home care, and hospitals.
  • Applications: Acute detection, risk assessment, and secondary prevention.
  • Geographies: Americas (United States by state, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (multiple countries including United Kingdom, Germany, UAE, South Africa), and Asia-Pacific (China, India, Japan, Australia, and more).
  • Key Companies: F. Hoffmann-La Roche AG, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, QuidelOrtho Corporation, Thermo Fisher Scientific Inc., bioMérieux SA, Becton, Dickinson and Company, Sysmex Corporation, Koninklijke Philips N.V.

Key Takeaways for Decision-Makers

  • High-sensitivity assays and digital point-of-care diagnostics enable faster cardiac event recognition, facilitating earlier intervention and improved resource allocation in both centralized and decentralized care settings.
  • Regulatory trends support accelerated approval for innovative tests, while simultaneously intensifying quality and compliance expectations, impacting both new entrants and established firms.
  • Strategic alliances, especially between diagnostics firms and technology providers, are advancing the implementation of machine learning and predictive analytics, refining risk stratification and patient monitoring.
  • Evolving care models emphasize multidisciplinary approaches, rapid clinical decision-making, and integration of diagnostic data into broader health IT ecosystems.
  • Regional differences require customized market tactics, with North America focusing on reimbursement alignment, Europe advancing device quality through elevated regulatory standards, and Asia-Pacific leveraging healthcare modernization and digital adoption.
  • Competition from both large multinational corporations with established distribution and innovative startups is reshaping product portfolios, integration capabilities, and the pace of technology adoption.

Tariff Impact: US Supply Chain and Cost Implications

Following the 2025 United States tariffs, manufacturers of heart attack diagnostics encountered higher costs for essential components, such as imported reagents and electronics. These adjustments prompted hospitals to reconsider procurement strategies and develop partnerships with regional suppliers. Small to mid-sized firms, in particular, responded by optimizing contract manufacturing agreements, sourcing tariff-exempt inputs, and investing in modular device architectures to balance production costs and supply continuity.

Methodology & Data Sources

Research integrates secondary analyses of scientific literature, regulatory filings, clinical trial data, and company disclosures with primary interviews featuring cardiologists, lab directors, and procurement leaders. Data triangulation validated trends in diagnostic utilization, technology deployment, and procurement. Quality assurance included peer review and expert validation to confirm accuracy and relevance for market stakeholders.

Why This Report Matters

  • Offers strategic perspectives for optimizing investments and aligning diagnostic portfolios with emerging care models and regulatory environments.
  • Equips leadership with actionable segmentation analysis, competitive dynamics, and practical supply chain insights for resilient growth and risk mitigation.

Conclusion

This report provides essential intelligence to support informed, agile decisions in a technology-driven and regulated heart attack diagnostics market. Executive teams can use these insights to strengthen market position, drive innovation, and respond proactively to sector challenges.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Heart Attack Diagnostics Market, by Product Type
8.1. Introduction
8.2. Biomarker Testing
8.2.1. CK-MB
8.2.2. Troponin I
8.2.3. Troponin T
8.3. Electrocardiography
8.3.1. Resting ECG
8.3.2. Stress ECG
8.4. Imaging
8.4.1. Computed Tomography
8.4.2. Magnetic Resonance Imaging
9. Heart Attack Diagnostics Market, by Technology
9.1. Introduction
9.2. Laboratory Based
9.2.1. High Sensitivity Troponin Assay
9.2.2. Immunoassay
9.3. Point of Care
9.3.1. Handheld Devices
9.3.2. Portable Devices
10. Heart Attack Diagnostics Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.3. Diagnostic Centers
10.4. Home Care
10.5. Hospitals
11. Heart Attack Diagnostics Market, by Application
11.1. Introduction
11.2. Acute Detection
11.3. Risk Assessment
11.4. Secondary Prevention
12. Americas Heart Attack Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Heart Attack Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Heart Attack Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche AG
15.3.2. Abbott Laboratories
15.3.3. Siemens Healthineers AG
15.3.4. Danaher Corporation
15.3.5. QuidelOrtho Corporation
15.3.6. Thermo Fisher Scientific Inc.
15.3.7. bioMérieux SA
15.3.8. Becton, Dickinson and Company
15.3.9. Sysmex Corporation
15.3.10. Koninklijke Philips N.V.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. HEART ATTACK DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. HEART ATTACK DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. HEART ATTACK DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HEART ATTACK DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HEART ATTACK DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HEART ATTACK DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY CK-MB, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TROPONIN I, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TROPONIN T, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY RESTING ECG, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STRESS ECG, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HIGH SENSITIVITY TROPONIN ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ACUTE DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY SECONDARY PREVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 60. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 61. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 62. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 64. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 65. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 69. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 70. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 71. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 73. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 115. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 116. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 117. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 119. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 124. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 125. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 126. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 128. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 129. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 142. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 143. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 144. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 146. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 147. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 151. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 152. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 153. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 155. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 156. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 178. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 187. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 188. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 189. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 191. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 192. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 205. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 206. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 207. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 209. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 210. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 214. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 215. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 216. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 218. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 219. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 241. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 242. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 243. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 245. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 246. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 250. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 251. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 252. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 254. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 255. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 268. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 269. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 270. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 271. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 272. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 273. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 277. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 278. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 279. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 281. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 282. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 286. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 287. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 303. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 305. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 306. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 307. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 308. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 309. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 310. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 313. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 314. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 315. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 316. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 317. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 318. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 319. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. JAPAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 322. JAPAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2030 (USD MILLION)
TABLE 323. JAPAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 324. JAPAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 325. JAPAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 326. JAPAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 327. JAPAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 328. JA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Heart Attack Diagnostics market report include:
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • QuidelOrtho Corporation
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • Sysmex Corporation
  • Koninklijke Philips N.V.

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 16.16 Billion
Forecasted Market Value ( USD ) by 2030 $ 23.49 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Heart Attack Diagnostics Market by Type, By Test, By End User, and By Region - Product Image

Heart Attack Diagnostics Market by Type, By Test, By End User, and By Region

  • Report
  • 200 Pages
  • Global
From
Heart Attack Diagnostics - Global Strategic Business Report - Product Image

Heart Attack Diagnostics - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Heart Attack Diagnostics Market Size, Share & Trends Analysis Report By Test (Electrocardiogram, Blood Test), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Heart Attack Diagnostics Market Size, Share & Trends Analysis Report By Test (Electrocardiogram, Blood Test), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Heart Attack Diagnostic Market Report 2025 - Product Image

Heart Attack Diagnostic Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Heart Attack Diagnostics Market 2024-2028 - Product Image

Heart Attack Diagnostics Market 2024-2028

  • Report
  • 146 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.